» Articles » PMID: 32220219

Chorioallantoic Membrane Assay As Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells

Overview
Date 2020 Mar 30
PMID 32220219
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue engineering aims to structurally and functionally regenerate damaged tissues, which requires the formation of new blood vessels that supply oxygen and nutrients by the process of angiogenesis. Stem cells are a promising tool in regenerative medicine due to their combined differentiation and paracrine angiogenic capacities. The study of their proangiogenic properties and associated potential for tissue regeneration requires complex models comprising all steps of the angiogenic process. The highly vascularized extraembryonic chorioallantoic membrane (CAM) of fertilized chicken eggs offers a simple, easy accessible, and cheap angiogenic screening tool compared to other animal models. Although the CAM assay was initially primarily performed for evaluation of tumor growth and metastasis, stem cell studies using this model are increasing. In this review, a detailed summary of angiogenic observations of different mesenchymal, cardiac, and endothelial stem cell types and derivatives in the CAM model is presented. Moreover, we focus on the variation in experimental setup, including the benefits and limitations of and protocols, diverse biological and synthetic scaffolds, imaging techniques, and outcome measures of neovascularization. Finally, advantages and disadvantages of the CAM assay as a model for angiogenesis in tissue engineering in comparison with alternative animal models are described. Impact statement The chorioallantoic membrane (CAM) assay is an easy and cheap screening tool for the angiogenic properties of stem cells and their associated potential in the tissue engineering field. This review offers an overview of all published angiogenic studies of stem cells using this model, with emphasis on the variation in used experimental timeline, culture protocol ( vs. ), stem cell type (derivatives), scaffolds, and outcome measures of vascularization. The purpose of this overview is to aid tissue engineering researchers to determine the ideal CAM experimental setup based on their specific study goals.

Citing Articles

A novel vascularized urethra-on-a-chip model.

Casademont-Roca A, Xing Z, Bernardi M, Rookmaker M, de Kort L, de Graaf P Sci Rep. 2025; 15(1):8062.

PMID: 40055501 PMC: 11889234. DOI: 10.1038/s41598-025-92485-9.


Biofunctionalization of silk fibroin scaffolds with enamel matrix protein and injectable platelet rich fibrin for soft tissue augmentation: an in-ovo study.

Heimes D, Wiesmann-Imilowski N, Heidebrecht T, Blatt S, Pabst A, Becker P Int J Implant Dent. 2025; 11(1):13.

PMID: 39976848 PMC: 11842663. DOI: 10.1186/s40729-025-00601-1.


Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis.

Abbasi-Malati Z, Khanicheragh P, Narmi M, Mardi N, Khosrowshahi N, Hiradfar A Stem Cell Res Ther. 2024; 15(1):267.

PMID: 39183337 PMC: 11346257. DOI: 10.1186/s13287-024-03880-4.


Advanced PEG-tyramine biomaterial ink for precision engineering of perfusable and flexible small-diameter vascular constructs via coaxial printing.

Siminska-Stanny J, Nicolas L, Chafai A, Jafari H, Hajiabbas M, Dodi G Bioact Mater. 2024; 36:168-184.

PMID: 38463551 PMC: 10924180. DOI: 10.1016/j.bioactmat.2024.02.019.


Hepatocellular carcinoma patients serum modulates the regenerative capacities of adipose mesenchymal stromal cells.

Salah R, El-Derby A, El-Gammal Z, Wadie B, Ahmed S, Elshenawy S Heliyon. 2024; 10(3):e24794.

PMID: 38333871 PMC: 10850426. DOI: 10.1016/j.heliyon.2024.e24794.